Moreover, reduced LDH-A expression was recently demonstrated to impact the proliferation and self-renewal of adenocarcinoma stem cells25, thus supporting a mechanistic rationale by which inhibition of LDH-A could also be a viable therapeutic target for GSCs. This evidence concerns the gene LDHA and adenocarcinoma.